Abstract
The expansion of a tandemly repeated trinucleotide sequence, CAG, is the mutational mechanism for several human genetic diseases. We present a generally applicable PCR amplification method using a fluorescently labelled locus specific primer flanking the CAG repeat together with paired primers amplifying from multiple priming sites within the CAG repeat. Triplet repeat primed PCR (TP PCR) gives a characteristic ladder on the fluorescence trace enabling the rapid identification of large pathogenetic CAG repeats that cannot be amplified using flanking primers. We used our method to test a cohort of 183 people from myotonic dystrophy families including unaffected subjects and spouses. Eighty five clinically affected subjects with expanded alleles on Southern blot analysis were all correctly identified by TP PCR. This method is applicable for any human diseases involving CAG repeat expansions. (JMed Genet 1996;33:1022-1026)
The expansion of the trinucleotide sequence CAG is the mutational mechanism for several human genetic diseases including myotonic dystrophy, Huntington's disease, spinocerebellar ataxia I and III, and dentatorubralpalludoluysian atrophy.`'5 Currently, for these diseases, PCR using flanking primers allows amplification up Traditionally, PCR amplification of these unstable DNA sequences involves the use of a pair of locus specific primers (P1, P2) that flank the variable trinucleotide sequence. Our PCR assay uses a specific flanking fluorescently labelled primer (P1) in concert with a pair of primers (P3, P4) which have a common 5' sequence (tail) (fig 1) . The common 5' sequence or tail primer (P3) was selected from an artificially produced random DNA sequence. The selection criteria for the sequence of the tail primer were (1) that it should contain little or no selfcomplementarity, (2) no complementarity with either (GCA)5 or (TGC)5, and (3) no homology to known human sequences. The paired primer (P4) has the sequence (GCA)5 or (TGC)5 at its 3' terminus depending on the strand of the CAG repeat to be amplified.
In the early amplification cycles the repeat specific 3' terminus of P4 primes at multiple sites within CAG repeat alleles giving rise to a mixture of products. Specificity is dictated by the fluorescent locus specific primer (P1). A 10:1 molar ratio of P3 to P4 ensures that primer P4 is exhausted in the early amplification cycles.
This reduces priming at (CAG)n sites internal to the PCR products produced in earlier rounds, which would result in a gradual shortening of the average PCR product size (fig 1) . The phenomenon of maintaining the allele size distribution by using a combination of tailed primer pairs was first described by Neil P2 fluoresceinated 1 ,umol/l) and P2 (1 1tmol/l) for conventional ampli&fation ofthe myotonic dystrophy CAG repeat, mix B: P 1 (5' fluoresceinated 1 pmol/l) with P3R (1 pmol/l) and P4CTG (0.1Ipmol/l), and mix C: P2 (5' fluoresceinated 1 jimol/l) with P3 (1 jimol/l) and P4CAG (0.1 imol/l) for amplifications priming from the CAG repeat allele. Samples were overlaid with mineral oil (Sigma) and incubated for four minutes at 94°C before the addition of the Taq polymerase. The reactions were subjected to 30 cycles of 94°C for one minute, 60°C for one minute, and 72°C for two minutes followed by a 10 minute extension at 72°C in a Perkin Elmer DNA thermal cycler. Five microlitres of each PCR product were added to 5 pl of distilled water and 10 pl of loading buffer (10 mg/ml blue dextran in deionised formamide) and incubated at 95°C for three minutes. Tubes were cooled on ice before loading on a denaturing 6% polyacrylamide 7 mol/l urea gel. PCR products were resolved by electrophoresis in 0.6 x TBE and visualised using an automatic laser fluorescent sequencer (ALF Pharmacia). Traces were analysed using the Pharmacia fragment manager software. 
